Pathstone Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Sell |
10,543
-8,595
| -45% | -$4.51M | 0.02% | 509 |
|
|
2025
Q1 | $12.1M | Buy |
19,138
+5,461
| +40% | +$3.46M | 0.05% | 273 |
|
|
2024
Q4 | $9.74M | Sell |
13,677
-1,254
| -8% | -$893K | 0.04% | 323 |
|
|
2024
Q3 | $15.7M | Buy |
14,931
+65
| +0.4% | +$68.3K | 0.07% | 207 |
|
|
2024
Q2 | $15.6M | Buy |
14,866
+40
| +0.3% | +$42K | 0.07% | 203 |
|
|
2024
Q1 | $14.3M | Buy |
14,826
+4,419
| +42% | +$4.25M | 0.07% | 213 |
|
|
2023
Q4 | $9.18M | Buy |
+10,407
| New | +$9.18M | 0.05% | 271 |
|